Resultado de búsqueda
David B. Sykes, M.D., Ph.D. Massachusetts General Hospital. Harvard Medical School. The Sykes lab aims to develop new treatments for patients with blood disorders, both benign (e.g. neutropenia), and malignant (e.g. leukemia). David Sykes's research group is focused on understanding myeloid development, and how this process goes awry in the ...
David B. Sykes. Massachusetts General Hospital. Verified email at mgh.harvard.edu - Homepage. Hematology Oncology Leukemia TEMPI Syndrome. Title. Sort. Sort by citations Sort by year Sort by...
David Sykes. Principal Investigator. David grew up on the chilly prairies of Edmonton, Alberta, Canada and completed his undergraduate degree in Biochemistry at the University of Alberta. He transitioned to La Jolla, CA to begin the Medical Scientist Training Program (MSTP) at the University of California San Diego.
David Sykes, M.D., Ph.D. Physician Investigator (Cl) Cancer Center, Mass General Research Institute. Assistant Professor of Medicine. Harvard Medical School. Assistant In Medicine. Medicine-Hematology/Oncology, Massachusetts General Hospital. Education. MD UCSD 2004. Research Interests.
David SYKES | Professor (Assistant) | M.D., Ph.D. | Massachusetts General Hospital, MA | MGH | Center for Regenerative Medicine | Research profile. About. 219. Publications. 27,863. Reads....
18 de ene. de 2018 · David Sykes, MD, PhD. Massachusetts General Hospital. Disease Area. Oncology. Focus. Development of New Treatments for Acute Myeloid Leukemia (AML) Scholar Profile. 2018 Harrington Scholar-Innovator. Albert Einstein said, “The most beautiful thing we can experience is the mysterious. It is the source of all true art and science.”
HOME / NEWS / David Sykes. A new way to target resistant cancer. August 6, 2020. Harvard researchers target chemotherapy-resistant leukemia by using metabolism. ... Read more. HSCI Principal Faculty members Suneet Agarwal and David Sykes receive the 2018 Harrington Scholar-Innovator Award. January 18, 2018.
